InvestorsHub Logo
Followers 18
Posts 3165
Boards Moderated 0
Alias Born 06/09/2010

Re: jaybe post# 34104

Thursday, 09/12/2013 2:31:56 PM

Thursday, September 12, 2013 2:31:56 PM

Post# of 80490
I am sure the trial is listed on clinicaltrials.gov.
My question was whether anyone knows if Tesaro will be presenting data from the trial.

Tesaro has licensing deals with Merck,Opko,and Amgen.
Opko also has an equity stake.
Tesaro acquired rights for TSR-011 from Amgen.

In March 2011, TESARO signed an agreement with Amgen Inc. for exclusive worldwide rights for the development, manufacture, commercialization and distribution of small molecule inhibitors of Anaplastic Lymphoma Kinase (ALK), including TSR-011. The agreement included an upfront payment and potential future payments and royalties associated with the achievement of certain development and commercial milestones.



http://www.tesarobio.com/licensing_agreements

I was interested in investing in OPKO and Tesaro but never pulled the trigger.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.